OTE Staff Reports

home

authors

ote-staff-reports

Dr Caroline Baumal provides an overview of the efficacy, safety and durability of faricimab in diabetic macular oedema (DMO) at ASRS 2021. In her presentation, Dr Baumal highlights results from the Phase 3 YOSEMITE and RHINE trials.

The American Society of Retina Specialists (ASRS) is hosting its 39th Annual Scientific Meeting from 8-12 October 2021, at the JW Marriott San Antonio Hill Country Resort and Spa in San Antonio, Texas.

Videos

Dr Caroline Baumal provides an overview of the efficacy, safety and durability of faricimab in diabetic macular oedema (DMO) at ASRS 2021.

Results from phase 3 YOSEMITE and RHINE trials on faricimab in DMO

Every second Thursday of October, the globe celebrates World Sight Day. Created by the International Agency for the Prevention of Blindness (IAPB), World Sight Day raises awareness of blindness and vision impairment.

This year's theme is #LoveYourEyes. We've asked ophthalmologists, optometrists, retina specialists, and members of the 

 team to share what their vision means to them and what they would miss seeing the most if they were to lose their vision.

The International Agency for the Prevention of Blindness has set a goal for 1 million people to pledge to get their eyes tested. Eye exams are one of the most effective ways to fight vision loss as clinicians can detect diseases early and begin sight-saving therapies.

 to get your eyes examined, and share your pledge to encourage others to do the same!

About the International Agency for the Prevention of Blindness

The International Agency for the Prevention of Blindness coordinates international blindness prevention activities and resources.

IAPB began in the mid-1970’s when Sir John Wilson and his colleagues drew attention to the growing issue of global blindness. In 1975, the IAPB was born, with Sir John Wilson at the helm as the Founder President. Additional founding members were the International Council of Ophthalmology (ICO) and the World Blind Union (WBU).

From the beginning, IAPB set its sights on linking professional bodies, non-governmental organisations, educational institutions and individuals in the fight against blindness. Today, it organises events, programmes and campaigns to combat vision loss.

World Sight Day is one of the IAPB’s largest initiatives every year, but they host events, educational resources and opportunities to fight blindness year-round. To learn more about how you can get involved in their fight against vision loss and impairment, visit their 

On October 14, we celebrate World Sight Day by pledging to receive annual eye exams, preventing or slowing vision loss, and showing love for our eyes.

How you #LoveYourEyes: clinicians, media, educators weigh in on World Sight Day 2021

Dr Ankur Shah, Prairie Eye Center, Springfield, IL, discusses the key highlights of his presentation titled "YUTIQ CALM: a real-world registry study of the fluocinolone acetonide intravitreal implant 0.18 mg in chronic non-infectious posterior uveitis," during the American Society of Retina Specialists' annual meeting in San Antonio, Texas. 

Find out what the results may mean for the future of patient care.

Dr Ankur Shah discusses key highlights of his presentation titled "YUTIQ CALM: a real-world registry study of the fluocinolone acetonide intravitreal implant 0.18 mg in chronic non-infectious posterior uveitis," during ASRS 2021. 

Chronic non-infectious posterior uveitis: Dissecting real-world registry study of YUTIQ

Dr Justis P. Ehlers, The Norman C. and Donna L. Harbert Endowed Chair for Ophthalmic Research, Cole Eye Institute, Cleveland, Ohio, speaks with 

 Sheryl Stevenson on the findings from a higher-order OCT analysis for inflammatory signal biomarkers in the HAWK Study. 

Are there predictive factors that clinicians can identify in patients who may be more at risk for developing inflammation so that they can mitigate risk? 

Learn what this research may mean for clinicians and their patients.

Dr Justis P. Ehlers discusses the findings from a higher-order OCT analysis for inflammatory signal biomarkers in the HAWK Study.

Author | OTE Staff Reports

Articles

How you #LoveYourEyes: clinicians, media, educators weigh in on World Sight Day 2021

Chronic non-infectious posterior uveitis: Dissecting real-world registry study of YUTIQ

HAWK study: Higher order OCT analysis for inflammatory signal biomarkers

Results from phase 3 YOSEMITE and RHINE trials on faricimab in DMO